|
|
Article: Biomet Announces Acquisition of the Assets of Cartilage Repair Company Cartilix.
- Article from:
- Blood Weekly
- Article date:
- November 5, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Biomet, Inc., a global leader in the manufacture of orthopedic and dental medical devices, announced its acquisition of the assets of Cartilix, a Foster City, CA based company that has developed proprietary cartilage repair technology (see also Biomet, Inc.).
Cartilix was founded in 2004 to develop cartilage repair and regeneration solutions. The company developed ChonDux™, a proprietary cartilage regeneration technology for repair of knee cartilage. ChonDux™ technology uses a biological adhesive and hydrogel to fill articular cartilage lesions.
ChonDux™ technology is not yet commercially available. Clinical trials are scheduled to ...
Related newspaper, magazine, and journal articles:
|